You are here

Effectiveness of GSK's malaria vaccine dwindles in 7 years


THE world's first malaria vaccine, developed by GlaxoSmithKline (GSK), provides some protection after three doses but its effect dwindles to almost nothing after seven years, scientists said on Wednesday.

Publishing a long-term study of the vaccine - called RTS,S or

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom